Clinical Spotlight Series

Use the ACC.21 Online Planner and Virtual Schedule to browse sessions.

Online Planner

ACC.21 Virtual Schedule

The Clinical Spotlight Series shines a light on best practices and emerging science across practice-changing topics in care including SGLT2i's, heart failure, lipid management, and anticoagulation.

Join leading experts in the field during ACC.21 for this series of interactive sessions to ensure you are up to date on the safety and efficacy of the newest therapies, and cultivate your skills in applying the latest clinical information into patient care.

Quick Links: SaturdaySunday

Saturday, May 15

Anticoagulation Trivia from A to V: Management Strategies Across the Board
6:05 – 7:20 p.m.
Session 1602 ● Guidelines Channel

There are multiple challenges facing clinicians when selecting the best anticoagulation treatment strategy for their patients. Come test your knowledge and compete against your peers at this cross-cutting interactive session covering anticoagulation for AFib, PAD, VTE, and COVID.


Tracking the CV Impact of SGLT2i's: Practice Essentials
6:05 – 7:35 p.m.
Session 1601 ● Topic Essentials 1 Channel

The rapid release of new trial results for sodium-glucose cotransporter 2 inhibitor (SGLT2i) and emerging indications demonstrate an exciting new treatment for patients at high cardiovascular risk. Join this expert-led session to gain insights on the latest science and practical applications you need to deliver cutting-edge therapy to your patients.


Sunday, May 16

What's New in HF Pharmacotherapies: The What, How, and Wow
6:05 – 7:35 p.m.
Session 1604 ● Topic Essentials 1 Channel

The treatment landscape for heart failure has evolved significantly, with exponential growth in clinical trials and therapeutic options. Join the experts as they help you navigate the new and complex management landscape, including understanding emerging therapies and their practical applications.


The Evolving Lipids Landscape: Current and Emerging Nonstatins
6:05 – 7:35 p.m.
Session 1605 ● Guidelines Channel

The ever-expanding wide spectrum of treatment options for ASCVD has drastically changed the lipid-lowering landscape. Understanding the nuanced considerations for patient selection is now more important than ever. Come join the experts to hear the latest strategies on appropriately using new nonstatin agents in clinical practice.


ACC Logo
ACC.21 on Social Media:
2021 American College of Cardiology Foundation. Visit
Terms and Conditions Registered User Agreement Advertising and Sponsorship Policy Privacy Policy Cookie Policy Contact Us